Document is current
Any future updates will be listed below
-
Authors
Roth Flach, Rachel J. http://orcid.org/0000-0003-2754-828X
Bollinger, Eliza
Reyes, Allan R.
Laforest, Brigitte
Kormos, Bethany L. http://orcid.org/0000-0003-2298-9369
Liu, Shenping http://orcid.org/0000-0001-9400-3007
Reese, Matthew R. http://orcid.org/0000-0002-1066-2652
Martinez Alsina, Luis A.
Buzon, Leanne
Zhang, Yuan
Bechle, Bruce
Rosado, Amy
Sahasrabudhe, Parag V. http://orcid.org/0000-0002-8442-637X
Knafels, John http://orcid.org/0000-0002-4636-9298
Bhattacharya, Samit K.
Omoto, Kiyoyuki
Stansfield, John C.
Hurley, Liam D.
Song, LouJin
Luo, Lina http://orcid.org/0000-0002-1406-7658
Breitkopf, Susanne B.
Monetti, Mara
Cunio, Teresa http://orcid.org/0000-0003-2505-5369
Tierney, Brendan
Geoly, Frank J.
Delmore, Jake
Siddall, C. Parker
Xue, Liang http://orcid.org/0000-0003-3606-4615
Yip, Ka N.
Kalgutkar, Amit S. http://orcid.org/0000-0001-9701-756X
Miller, Russell A.
Zhang, Bei B.
Filipski, Kevin J. http://orcid.org/0000-0003-0845-5723
-
Funding
Funding for this research was provided by:
Pfizer (N/A)
- License Information
-
More Information
Article History
Received: 14 December 2022
Accepted: 25 July 2023
First Online: 9 August 2023
Competing interests
: All authors are employees of Pfizer Inc. or were employees at the time the research was conducted. Multiple authors own Pfizer stock. The following authors are inventors on patents or patent applications for BDK inhibitors: R.J.R.F., B.L.K., S.L., M.R.R., L.A.M.A., L.B., Y.Z., S.K.B., K.O., R.A.M., K.J.F.. The other authors have no additional competing interests to declare.
